• Patient Education

Patient Education: Elotuzumab (Empliciti) - Anti-SLAMF7 Monoclonal Antibody - Immunotherapy

Patient Education: Elotuzumab (Empliciti) - Anti-SLAMF7 Monoclonal Antibody - Immunotherapy

Elotuzumab

ELOTUZUMAB (EMPLICITI)


NIH National cancer institute - cancer.gov site info

This page contains brief information and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Empliciti

FDA Approved: Yes

Learn more: https://www.cancer.gov/about-cancer/treatment/drugs/elotuzumab

 

MedlinePlus Information

A lay language summary of important information about this drug that may include the following:

warnings about this drug,

what this drug is used for and how it is used,

what you should tell your doctor before using this drug,

what you should know about this drug before using it,

other drugs that may interact with this drug, and

possible side effects.

Learn more: https://medlineplus.gov/druginfo/meds/a616001.html

 

Information on Empliciti website

https://www.empliciti.com/about/starting-empliciti

 

INTERNATIONAL MYELOMA FOUNDATION:


Understanding Empliciti

https://www.myeloma.org/resource-library/understanding-empliciti

Download Booklet here


IMF Understanding Series

https://www.myeloma.org/cancer-information-series


IMF Resource Library

https://www.myeloma.org

https://www.myeloma.org/publications-videos

https://www.youtube.com/c/IMFMyeloma/videos


Current FDA-Approved Medications for Multiple Myeloma Treatment

https://www.myeloma.org/multiple-myeloma-drugs

 

HEALTH TREE UNIVERSITY MYELOMA:


All About Empliciti (Elotuzumab)

Watch Video on YouTube


HealthTree University for Multiple Myeloma Lectures

https://healthtree.org/myeloma/university/courses

https://healthtree.org/


Health Tree University Myeloma Videos

https://www.youtube.com/c/HealthTreeUniversity/videos

 

MULTIPLE MYELOMA RESERACH FOUNDATION:


Standard Treatments - Elotuzumab (Empliciti) - Anti-SLAMF7 Monoclonal Antibody - Immunotherapy

https://themmrf.org/multiple-myeloma/treatment-options/standard-treatments/empliciti/

https://themmrf.org/multiple-myeloma/treatment-options/standard-treatments/


MMRF Education Programs

https://themmrf.org/resources/education-programs/

https://themmrf.org/


MMRF Videos

https://www.youtube.com/user/TheMMRF/videos

 

References EMPLICITI:


FDA Label Prescribing Information

Prescribing Information | EMPLICITI


Drug Label Information at DAILYMED - NIH-National Library of Medicine

DailyMed - EMPLICITI- elotuzumab injection, powder, lyophilized, for solution


Other Rsources

Resources & Support

 


- Multiple Myeloma Patient Education & Information on ongoing Multiple Myeloma Clinical Trials -



Posts Archive